## DOV KADMON

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Urology  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=MqAx5WjILqv3RYKj5X%2fX&rnd=2d07f4a0-327f-46cd-
ab83-b904029aed5a)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=268024)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=268024&cachekey=47c0cf7a-491d-488d-adea-962ed68b5691)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

R01CA044274 (KADMON, DOV)Jul 1, 1986 - Jun 30, 1989NIH  
POLYAMINE BASED SCAN FOR METASTATIC PROSTATE CANCER  
Role: Principal Investigator  
---  
  
* * *  
  
K04CA001248 (KADMON, DOV)May 1, 1986 - Mar 31, 1989NIH  
POLYAMINE BASED SCAN FOR METASTATIC PROSTATE CANCER  
Role: Principal Investigator  
  
* * *  
  
K04CA000931 (KADMON, DOV)Apr 15, 1984 - Mar 31, 1989NIH  
POLYAMINE BASED SCAN FOR METASTATIC PROSTATE CANCER  
Role: Principal Investigator  
  
* * *  
  
R01CA034873 (KADMON, DOV)May 1, 1983 - Apr 30, 1986NIH  
POLYAMINE BASED SCAN FOR METASTATIC PROSTATE CANCER  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Hinojosa-Gonz?lez DE, Saffati G, Kronstedt S, La T, Chiu C, Wahlstedt E, Jones JA, **Kadmon D** , [Badal J](https://profiles.viictr.org/profile/38374049), Taylor JM, [Slawin JR](https://profiles.viictr.org/profile/38937051). Comparison of peritoneal interposition flaps and sealants for prevention of lymphocele after robotic radical prostatectomy and pelvic lymph node dissection: a systematic review, meta-analysis, Bayesian network meta-analysis, and meta-regression. J Robot Surg. 2024 Apr 17; 18(1):177. PMID: [38630430](//www.ncbi.nlm.nih.gov/pubmed/38630430).

Citations:  Fields:

Gen General SurgeryTec Technology

Translation:Humans

  2. Hinojosa-Gonzalez DE, Nolazco JI, Saffati G, Kronstedt S, Jones JA, Kadmon D, [Badal J](https://profiles.viictr.org/profile/38374049), [Slawin JR](https://profiles.viictr.org/profile/38937051), Hinojosa-Gonzalez DE, Nolazco JI, Saffati G, Kronstedt S, Jones JA, **Kadmon D** , Badal J, Slawin JR. Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis. Eur Urol Focus. 2024 Mar; 10(2):234-241. PMID: [38242825](//www.ncbi.nlm.nih.gov/pubmed/38242825).

Citations:  Fields:

Uro Urology

  3. Coarfa C, Florentin D, [Putluri N](https://profiles.viictr.org/profile/269361), Ding Y, Au J, He D, Ragheb A, Frolov A, Michailidis G, Lee M, **Kadmon D** , [Miles B](https://profiles.viictr.org/profile/268161), Smith C, [Ittmann M](https://profiles.viictr.org/profile/269566), [Rowley D](https://profiles.viictr.org/profile/269631), [Sreekumar A](https://profiles.viictr.org/profile/266636), [Creighton CJ](https://profiles.viictr.org/profile/265729), Ayala G. Influence of the neural microenvironment on prostate cancer. Prostate. 2018 Feb; 78(2):128-139. PMID: [29131367](//www.ncbi.nlm.nih.gov/pubmed/29131367); PMCID: [PMC5836952](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5836952).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29131367/citedby/) Fields:

Uro Urology

Translation:Animals

  4. De Vivar AD, Sayeeduddin M, [Rowley D](https://profiles.viictr.org/profile/269631), Cubilla A, [Miles B](https://profiles.viictr.org/profile/268161), **Kadmon D** , Ayala G. Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3). Hum Pathol. 2017 05; 63:202-211. PMID: [28315427](//www.ncbi.nlm.nih.gov/pubmed/28315427).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28315427/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  5. Ding Y, He D, Florentin D, Frolov A, [Hilsenbeck S](https://profiles.viictr.org/profile/268374), [Ittmann M](https://profiles.viictr.org/profile/269566), **Kadmon D** , [Miles B](https://profiles.viictr.org/profile/268161), [Rowley D](https://profiles.viictr.org/profile/269631), Ayala G. Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6101-11. PMID: [24097862](//www.ncbi.nlm.nih.gov/pubmed/24097862); PMCID: [PMC3898797](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3898797).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24097862/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  6. Sonpavde G, Wang M, Peterson LE, Wang HY, Joe T, Mims MP, **Kadmon D** , [Ittmann MM](https://profiles.viictr.org/profile/269566), [Wheeler TM](https://profiles.viictr.org/profile/266558), [Gee AP](https://profiles.viictr.org/profile/268378), Wang RF, Hayes TG. HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs. 2014 Apr; 32(2):235-242. PMID: [23609828](//www.ncbi.nlm.nih.gov/pubmed/23609828); PMCID: [PMC4100683](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4100683).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23609828/citedby/) Fields:

Ant Antineoplastic AgentsPha Pharmacology

Translation:HumansCellsCTClinical Trials

  7. Sonpavde G, [Thompson TC](https://profiles.viictr.org/profile/12582753), Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, [Ittmann MM](https://profiles.viictr.org/profile/269566), [Wheeler TM](https://profiles.viictr.org/profile/266558), [Gee A](https://profiles.viictr.org/profile/268378), [Miles BJ](https://profiles.viictr.org/profile/268161), **Kadmon D**. GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomy. Clin Cancer Res. 2011 Nov 15; 17(22):7174-82. PMID: [21933889](//www.ncbi.nlm.nih.gov/pubmed/21933889); PMCID: [PMC3865786](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3865786).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21933889/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  8. Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, [Liu H](https://profiles.viictr.org/profile/265543), Scardino PT, Li R, Sayeeduddin M, [Ittmann MM](https://profiles.viictr.org/profile/269566), **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), [Rowley DR](https://profiles.viictr.org/profile/269631). Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens. Am J Pathol. 2011 Jan; 178(1):79-87. PMID: [21224046](//www.ncbi.nlm.nih.gov/pubmed/21224046); PMCID: [PMC3069909](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3069909).

Citations:
[27](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21224046/citedby/) Fields:

Pat Pathology

Translation:Humans

  9. [Thompson TC](https://profiles.viictr.org/profile/12582753), Tahir SA, [Li L](https://profiles.viictr.org/profile/12583886), Watanabe M, Naruishi K, [Yang G](https://profiles.viictr.org/profile/12582752), **Kadmon D** , [Logothetis CJ](https://profiles.viictr.org/profile/12583246), [Troncoso P](https://profiles.viictr.org/profile/12582902), Ren C, Goltsov A, Park S. The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis. 2010 Mar; 13(1):6-11. PMID: [19581923](//www.ncbi.nlm.nih.gov/pubmed/19581923); PMCID: [PMC2887695](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2887695).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19581923/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCells

  10. Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, [Yang G](https://profiles.viictr.org/profile/12582752), Abdel Fattah E, Wang J, Goltsov A, Floryk D, Soni SD, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer. Prostate Cancer Prostatic Dis. 2009; 12(3):301-9. PMID: [19104507](//www.ncbi.nlm.nih.gov/pubmed/19104507).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19104507/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:AnimalsCells

  11. Ayala GE, Dai H, Powell M, Li R, Ding Y, [Wheeler TM](https://profiles.viictr.org/profile/266558), Shine D, **Kadmon D** , [Thompson T](https://profiles.viictr.org/profile/12582753), [Miles BJ](https://profiles.viictr.org/profile/268161), [Ittmann MM](https://profiles.viictr.org/profile/269566), [Rowley D](https://profiles.viictr.org/profile/269631). Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7593-603. PMID: [19047084](//www.ncbi.nlm.nih.gov/pubmed/19047084).

Citations:
[122](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19047084/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  12. Ayala G, Yan J, Li R, Ding Y, [Thompson TC](https://profiles.viictr.org/profile/12582753), Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Harper JW, Tsai MJ, [Ittmann MM](https://profiles.viictr.org/profile/269566), **Kadmon D**. Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt. Clin Cancer Res. 2008 Nov 15; 14(22):7511-8. PMID: [19010869](//www.ncbi.nlm.nih.gov/pubmed/19010869); PMCID: [PMC2820291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2820291).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19010869/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  13. Tahir SA, [Yang G](https://profiles.viictr.org/profile/12582752), Goltsov AA, Watanabe M, Tabata K, Addai J, Fattah el MA, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res. 2008 Feb 01; 68(3):731-9. PMID: [18245473](//www.ncbi.nlm.nih.gov/pubmed/18245473).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18245473/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  14. Yanagisawa N, Li R, [Rowley D](https://profiles.viictr.org/profile/269631), [Liu H](https://profiles.viictr.org/profile/265543), **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Ayala GE. Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2008 Feb; 39(2):282-91. PMID: [18206496](//www.ncbi.nlm.nih.gov/pubmed/18206496).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18206496/citedby/) Fields:

Pat Pathology

  15. Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, **Kadmon D**. Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer. Cancer. 2007 Dec 15; 110(12):2628-39. PMID: [17941029](//www.ncbi.nlm.nih.gov/pubmed/17941029).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17941029/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  16. Yanagisawa N, Li R, [Rowley D](https://profiles.viictr.org/profile/269631), [Liu H](https://profiles.viictr.org/profile/265543), **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Ayala GE. Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy. Hum Pathol. 2007 Nov; 38(11):1611-20. PMID: [17868773](//www.ncbi.nlm.nih.gov/pubmed/17868773).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17868773/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  17. [Yang G](https://profiles.viictr.org/profile/12582752), Addai J, [Wheeler TM](https://profiles.viictr.org/profile/266558), Frolov A, [Miles BJ](https://profiles.viictr.org/profile/268161), **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol. 2007 Nov; 38(11):1688-95. PMID: [17707459](//www.ncbi.nlm.nih.gov/pubmed/17707459).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17707459/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  18. Teh BS, Bastasch MD, Mai WY, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), Butler EB. Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy. Am J Clin Oncol. 2007 Aug; 30(4):395-400. PMID: [17762440](//www.ncbi.nlm.nih.gov/pubmed/17762440).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  19. Wang H, [Yang G](https://profiles.viictr.org/profile/12582752), Timme TL, Fujita T, Naruishi K, Frolov A, Brenner MK, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer. Cancer Gene Ther. 2007 Oct; 14(10):819-27. PMID: [17627292](//www.ncbi.nlm.nih.gov/pubmed/17627292).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17627292/citedby/) Fields:

Gen GeneticsNeo NeoplasmsThe Therapeutics

Translation:AnimalsCells

  20. Tahir SA, Frolov A, Hayes TG, Mims MP, [Miles BJ](https://profiles.viictr.org/profile/268161), [Lerner SP](https://profiles.viictr.org/profile/267959), [Wheeler TM](https://profiles.viictr.org/profile/266558), Ayala G, [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D**. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res. 2006 Aug 15; 12(16):4872-5. PMID: [16914574](//www.ncbi.nlm.nih.gov/pubmed/16914574).

Citations:
[32](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16914574/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  21. Teh BS, Bastasch MD, Mai WY, Kattan MW, Butler EB, **Kadmon D**. Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins. J Urol. 2006 Jun; 175(6):2097-101; discussion 2101-2. PMID: [16697811](//www.ncbi.nlm.nih.gov/pubmed/16697811).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16697811/citedby/) Fields:

Uro Urology

Translation:Humans

  22. Ayala G, Satoh T, Li R, Shalev M, Gdor Y, Aguilar-Cordova E, Frolov A, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Miles BJ](https://profiles.viictr.org/profile/268161), Rauen K, Teh BS, Butler EB, [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D**. Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer. Mol Ther. 2006 Apr; 13(4):716-28. PMID: [16480930](//www.ncbi.nlm.nih.gov/pubmed/16480930).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16480930/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCellsCTClinical Trials

  23. [Tetzlaff MT](https://profiles.viictr.org/profile/12583171), Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), Ayala G, [Wheeler TM](https://profiles.viictr.org/profile/266558), Aguilar-Cordova E, [Thompson TC](https://profiles.viictr.org/profile/12582753), Butler EB. Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol Cancer Res Treat. 2006 Feb; 5(1):23-36. PMID: [16417399](//www.ncbi.nlm.nih.gov/pubmed/16417399).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16417399/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimals

  24. Koh MS, [Ittmann M](https://profiles.viictr.org/profile/269566), **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753), Leach FS. CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer. Cancer Biol Ther. 2006 Jan; 5(1):78-83. PMID: [16357515](//www.ncbi.nlm.nih.gov/pubmed/16357515).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16357515/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  25. Cyrus-David MS, [Weinberg A](https://profiles.viictr.org/profile/268624), [Thompson T](https://profiles.viictr.org/profile/12582753), **Kadmon D**. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report. J Urol. 2005 Jun; 173(6):1923-5. PMID: [15879782](//www.ncbi.nlm.nih.gov/pubmed/15879782).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15879782/citedby/) Fields:

Uro Urology

Translation:Humans

  26. van der Linden RR, Haagmans BL, Mongiat-Artus P, van Doornum GJ, Kraaij R, **Kadmon D** , Aguilar-Cordova E, Osterhaus AD, van der Kwast TH, Bangma CH. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol. 2005 Jul; 48(1):153-61. PMID: [15967266](//www.ncbi.nlm.nih.gov/pubmed/15967266).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15967266/citedby/) Fields:

Uro Urology

Translation:HumansCellsCTClinical Trials

  27. Karakiewicz P, Shariat SF, Naderi A, **Kadmon D** , Slawin KM. Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer. Urology. 2005 Jan; 65(1):131-5. PMID: [15667878](//www.ncbi.nlm.nih.gov/pubmed/15667878).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15667878/citedby/) Fields:

Uro Urology

Translation:Humans

  28. [Li L](https://profiles.viictr.org/profile/12583886), [Ittmann MM](https://profiles.viictr.org/profile/269566), Ayala G, [Tsai MJ](https://profiles.viictr.org/profile/267651), Amato RJ, [Wheeler TM](https://profiles.viictr.org/profile/266558), Miles BJ, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). The emerging role of the PI3-K-Akt pathway in prostate cancer progression. Prostate Cancer Prostatic Dis. 2005; 8(2):108-18. PMID: [15724144](//www.ncbi.nlm.nih.gov/pubmed/15724144).

Citations:
[54](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15724144/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansCells

  29. Canto EI, Singh H, Shariat SF, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol. 2004 Sep; 172(3):900-4. PMID: [15310993](//www.ncbi.nlm.nih.gov/pubmed/15310993).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15310993/citedby/) Fields:

Uro Urology

Translation:Humans

  30. Satoh T, Teh BS, Timme TL, Mai WY, Gdor Y, Kusaka N, Fujita T, Pramudji CK, Vlachaki MT, Ayala G, [Wheeler T](https://profiles.viictr.org/profile/266558), Amato R, [Miles BJ](https://profiles.viictr.org/profile/268161), **Kadmon D** , Butler EB, [Thompson TC](https://profiles.viictr.org/profile/12582753). Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2004 Jun 01; 59(2):562-71. PMID: [15145177](//www.ncbi.nlm.nih.gov/pubmed/15145177).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15145177/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansCellsCTClinical Trials

  31. Singh H, Canto EI, Shariat SF, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol. 2004 May; 171(5):1850-4. PMID: [15076292](//www.ncbi.nlm.nih.gov/pubmed/15076292).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15076292/citedby/) Fields:

Uro Urology

Translation:Humans

  32. Canto EI, Singh H, Shariat SF, Lamb DJ, Mikolajczyk SD, Linton HJ, Rittenhouse HG, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), Slawin KM. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer. Urology. 2004 May; 63(5):905-10; discussion 910-1. PMID: [15134977](//www.ncbi.nlm.nih.gov/pubmed/15134977).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15134977/citedby/) Fields:

Uro Urology

Translation:Humans

  33. Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, [Miles B](https://profiles.viictr.org/profile/268161), **Kadmon D** , [Wheeler T](https://profiles.viictr.org/profile/266558), Caillouet J, Davis M, Carpenter LS, [Lu HH](https://profiles.viictr.org/profile/267845), Chiu JK, Woo SY, [Thompson T](https://profiles.viictr.org/profile/12582753), Aguilar-Cordova E, Butler EB. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1520-9. PMID: [15050332](//www.ncbi.nlm.nih.gov/pubmed/15050332).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15050332/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansCellsCTClinical Trials

  34. Singh H, Canto EI, Shariat SF, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol. 2004 Mar; 171(3):1089-92. PMID: [14767277](//www.ncbi.nlm.nih.gov/pubmed/14767277).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14767277/citedby/) Fields:

Uro Urology

Translation:Humans

  35. Singh H, Canto EI, Shariat SF, **Kadmon D** , [Miles BJ](https://profiles.viictr.org/profile/268161), [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. J Urol. 2004 Jan; 171(1):204-9. PMID: [14665877](//www.ncbi.nlm.nih.gov/pubmed/14665877).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14665877/citedby/) Fields:

Uro Urology

Translation:Humans

  36. Cao G, [Yang G](https://profiles.viictr.org/profile/12582752), Timme TL, Saika T, [Truong LD](https://profiles.viictr.org/profile/267800), Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, **Kadmon D** , Cai WW, Chinault AC, Boone TB, Bradley A, [Thompson TC](https://profiles.viictr.org/profile/12582753). Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol. 2003 Apr; 162(4):1241-8. PMID: [12651616](//www.ncbi.nlm.nih.gov/pubmed/12651616); PMCID: [PMC1851223](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1851223).

Citations:
[40](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12651616/citedby/) Fields:

Pat Pathology

Translation:Animals

  37. Timme TL, Satoh T, Tahir SA, Wang H, Teh BS, Butler EB, [Miles BJ](https://profiles.viictr.org/profile/268161), Amato RJ, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Therapeutic targets for metastatic prostate cancer. Curr Drug Targets. 2003 Apr; 4(3):251-61. PMID: [12643475](//www.ncbi.nlm.nih.gov/pubmed/12643475).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12643475/citedby/) Fields:

Dru Drug Therapy

Translation:HumansAnimals

  38. Mouraviev V, [Li L](https://profiles.viictr.org/profile/12583886), Tahir SA, [Yang G](https://profiles.viictr.org/profile/12582752), Timme TM, Goltsov A, Ren C, Satoh T, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Ittmann MM](https://profiles.viictr.org/profile/269566), [Miles BJ](https://profiles.viictr.org/profile/268161), Amato RJ, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). The role of caveolin-1 in androgen insensitive prostate cancer. J Urol. 2002 Oct; 168(4 Pt 1):1589-96. PMID: [12352463](//www.ncbi.nlm.nih.gov/pubmed/12352463).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12352463/citedby/) Fields:

Uro Urology

Translation:HumansAnimals

  39. Bastasch MD, Teh BS, Mai WY, Carpenter LS, [Lu HH](https://profiles.viictr.org/profile/267845), Chiu JK, Woo SY, Grant WH, [Miles BJ](https://profiles.viictr.org/profile/268161), **Kadmon D** , Butler EB. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys. 2002 Sep 01; 54(1):101-6. PMID: [12182979](//www.ncbi.nlm.nih.gov/pubmed/12182979).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12182979/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  40. Gdor Y, Timme TL, [Miles BJ](https://profiles.viictr.org/profile/268161), **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Gene therapy for prostate cancer. Expert Rev Anticancer Ther. 2002 Jun; 2(3):309-21. PMID: [12113054](//www.ncbi.nlm.nih.gov/pubmed/12113054).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12113054/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansCells

  41. Matsumoto AM, Tenover L, McClung M, Mobley D, Geller J, Sullivan M, Grayhack J, Wessells H, **Kadmon D** , Flanagan M, Zhang GK, Schmidt J, Taylor AM, Lee M, Waldstreicher J, Pless Study Group. The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial. J Urol. 2002 May; 167(5):2105-8. PMID: [11956450](//www.ncbi.nlm.nih.gov/pubmed/11956450).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11956450/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  42. Teh BS, Aguilar-Cordova E, Vlachaki MT, Aguilar L, Mai WY, Caillouet J, Davis M, [Miles B](https://profiles.viictr.org/profile/268161), **Kadmon D** , Ayala G, [Lu HH](https://profiles.viictr.org/profile/267845), Chiu JK, Carpenter LS, Woo SY, Grant WH, [Wheeler T](https://profiles.viictr.org/profile/266558), [Thompson TC](https://profiles.viictr.org/profile/12582753), Butler EB. Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist. 2002; 7(5):458-66. PMID: [12401909](//www.ncbi.nlm.nih.gov/pubmed/12401909).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12401909/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCellsCTClinical Trials

  43. **Kadmon D**. Radiation therapy after radical prostatectomy: strike early, strike hard! The case for adjuvant radiation therapy. Rev Urol. 2002; 4(2):87-9. PMID: [16985660](//www.ncbi.nlm.nih.gov/pubmed/16985660); PMCID: [PMC1475975](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1475975).

Citations:

  44. Kim ED, Nath R, Slawin KM, **Kadmon D** , Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology. 2001 Dec; 58(6):983-7. PMID: [11744473](//www.ncbi.nlm.nih.gov/pubmed/11744473).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11744473/citedby/) Fields:

Uro Urology

Translation:Humans

  45. Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, [Yang G](https://profiles.viictr.org/profile/12582752), Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, [Wheeler TM](https://profiles.viictr.org/profile/266558), Butler EB, **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753). Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy. Hum Gene Ther. 2001 Nov 01; 12(16):1955-67. PMID: [11686937](//www.ncbi.nlm.nih.gov/pubmed/11686937).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11686937/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  46. Teh BS, Aguilar-Cordova E, Kernen K, Chou CC, Shalev M, Vlachaki MT, Miles B, **Kadmon D** , Mai WY, Caillouet J, Davis M, Ayala G, [Wheeler T](https://profiles.viictr.org/profile/266558), Brady J, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Butler EB. Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):605-13. PMID: [11597799](//www.ncbi.nlm.nih.gov/pubmed/11597799).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11597799/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansCellsCTClinical Trials

  47. Kim ED, Nath R, **Kadmon D** , [Lipshultz LI](https://profiles.viictr.org/profile/266450), Miles BJ, Slawin KM, Tang HY, [Wheeler T](https://profiles.viictr.org/profile/266558), Scardino PT. Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup. J Urol. 2001 Jun; 165(6 Pt 1):1950-6. PMID: [11371887](//www.ncbi.nlm.nih.gov/pubmed/11371887).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11371887/citedby/) Fields:

Uro Urology

Translation:Humans

  48. [Thompson TC](https://profiles.viictr.org/profile/12582753), Timme TL, Ebara S, Satoh T, Yang G, Wang J, Miles BJ, Ayala G, [Wheeler TM](https://profiles.viictr.org/profile/266558), **Kadmon D**. In situ gene therapy for prostate cancer: immunomodulatory approaches. Expert Opin Biol Ther. 2001 May; 1(3):481-95. PMID: [11727520](//www.ncbi.nlm.nih.gov/pubmed/11727520).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11727520/citedby/) Fields:

Bio BiologyThe Therapeutics

Translation:HumansAnimals

  49. Gore JL, Shariat SF, Miles BJ, **Kadmon D** , Jiang N, [Wheeler TM](https://profiles.viictr.org/profile/266558), Slawin KM. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol. 2001 May; 165(5):1554-9. PMID: [11342916](//www.ncbi.nlm.nih.gov/pubmed/11342916).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11342916/citedby/) Fields:

Uro Urology

Translation:Humans

  50. Sukin SW, Chhikara M, Zhu X, Ayala G, Aguilar LK, O'Brian Smith E, Miles BJ, [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D** , Aguilar-Cordova E. In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer. Mol Ther. 2001 Apr; 3(4):500-6. PMID: [11319910](//www.ncbi.nlm.nih.gov/pubmed/11319910).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11319910/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:AnimalsCells

  51. Kim ED, Scardino PT, **Kadmon D** , Slawin K, Nath RK. Interposition sural nerve grafting during radical retropubic prostatectomy. Urology. 2001 Feb; 57(2):211-6. PMID: [11182323](//www.ncbi.nlm.nih.gov/pubmed/11182323).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11182323/citedby/) Fields:

Uro Urology

Translation:HumansAnimals

  52. Shalev M, [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D** , Ayala G, Kernen K, Miles BJ. Gene therapy for prostate cancer. Urology. 2001 Jan; 57(1):8-16. PMID: [11164134](//www.ncbi.nlm.nih.gov/pubmed/11164134).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11164134/citedby/) Fields:

Uro Urology

Translation:HumansCells

  53. Thaller C, Shalev M, Frolov A, [Eichele G](https://profiles.viictr.org/profile/268289), [Thompson TC](https://profiles.viictr.org/profile/12582753), Williams RH, Dillioglugil O, **Kadmon D**. Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration. J Clin Oncol. 2000 Nov 15; 18(22):3804-8. PMID: [11078493](//www.ncbi.nlm.nih.gov/pubmed/11078493).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11078493/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCTClinical Trials

  54. Shalev M, [Thompson TC](https://profiles.viictr.org/profile/12582753), Frolov A, Lippman SM, Hong WK, Fritsche H, **Kadmon D**. Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy. Clin Cancer Res. 2000 Oct; 6(10):3845-9. PMID: [11051228](//www.ncbi.nlm.nih.gov/pubmed/11051228).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11051228/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  55. Ayala G, [Wheeler TM](https://profiles.viictr.org/profile/266558), Shalev M, [Thompson TC](https://profiles.viictr.org/profile/12582753), Miles B, Aguilar-Cordova E, Chakraborty S, **Kadmon D**. Cytopathic effect of in situ gene therapy in prostate cancer. Hum Pathol. 2000 Jul; 31(7):866-70. PMID: [10923926](//www.ncbi.nlm.nih.gov/pubmed/10923926).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10923926/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  56. Shalev M, **Kadmon D** , Teh BS, Butler EB, Aguilar-Cordova E, [Thompson TC](https://profiles.viictr.org/profile/12582753), Herman JR, Adler HL, Scardino PT, Miles BJ. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. J Urol. 2000 Jun; 163(6):1747-50. PMID: [10799174](//www.ncbi.nlm.nih.gov/pubmed/10799174).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10799174/citedby/) Fields:

Uro Urology

Translation:HumansCells

  57. Smith VC, Edwards RA, [Jorgensen JL](https://profiles.viictr.org/profile/12583424), Goldfarb RA, **Kadmon D** , Cagle P, Truong LD. Unilocular retroperitoneal cyst of mesothelial origin presenting as a renal mass. Arch Pathol Lab Med. 2000 May; 124(5):766-9. PMID: [10782166](//www.ncbi.nlm.nih.gov/pubmed/10782166).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10782166/citedby/) Fields:

Pat Pathology

Translation:Humans

  58. Shalev M, Miles BJ, [Thompson TC](https://profiles.viictr.org/profile/12582753), Ayala G, Butler EB, Aguilar-Cordova E, **Kadmon D**. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene. World J Urol. 2000 Apr; 18(2):125-9. PMID: [10854147](//www.ncbi.nlm.nih.gov/pubmed/10854147).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10854147/citedby/) Fields:

Uro Urology

Translation:HumansCells

  59. **Kadmon D**. Beyond prostate specific antigen--markers for prostate cancer for the 21st Century. J Urol. 2000 Mar; 163(3):828. PMID: [10687986](//www.ncbi.nlm.nih.gov/pubmed/10687986).

Citations:  Fields:

Uro Urology

Translation:Humans

  60. Lotan Y, Xu XC, Shalev M, Lotan R, Williams R, [Wheeler TM](https://profiles.viictr.org/profile/266558), [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D**. Differential expression of nuclear retinoid receptors in normal and malignant prostates. J Clin Oncol. 2000 Jan; 18(1):116-21. PMID: [10623701](//www.ncbi.nlm.nih.gov/pubmed/10623701).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10623701/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  61. Shaker MR, [Yang G](https://profiles.viictr.org/profile/12582752), Timme TL, Park SH, **Kadmon D** , Ren C, Ji X, Lee HM, Sehgal I, Anzano M, Sporn MB, [Thompson TC](https://profiles.viictr.org/profile/12582753). Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression. Clin Exp Metastasis. 2000; 18(5):429-38. PMID: [11467776](//www.ncbi.nlm.nih.gov/pubmed/11467776).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/11467776/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  62. Smith CP, Sharma A, Ayala G, Cagle P, **Kadmon D**. Solitary pulmonary metastasis from prostate cancer. J Urol. 1999 Dec; 162(6):2102. PMID: [10569587](//www.ncbi.nlm.nih.gov/pubmed/10569587).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10569587/citedby/) Fields:

Uro Urology

Translation:Humans

  63. Andriole GL, Guess HA, Epstein JI, Wise H, **Kadmon D** , Crawford ED, Hudson P, Jackson CL, Romas NA, Patterson L, Cook TJ, Waldstreicher J. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology. 1998 Aug; 52(2):195-201; discussion 201-2. PMID: [9697781](//www.ncbi.nlm.nih.gov/pubmed/9697781).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9697781/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  64. Leis PF, Stevens KR, Baer SC, **Kadmon D** , Goldberg LH, Wang XJ. A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression. Cancer. 1998 Jul 01; 83(1):122-9. PMID: [9655301](//www.ncbi.nlm.nih.gov/pubmed/9655301).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9655301/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  65. Sutton MA, Watkins HL, Green LK, **Kadmon D**. Intracranial metastases as the first manifestation of prostate cancer. Urology. 1996 Nov; 48(5):789-93. PMID: [8911530](//www.ncbi.nlm.nih.gov/pubmed/8911530).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8911530/citedby/) Fields:

Uro Urology

Translation:Humans

  66. **Kadmon D** , Weinberg AD, Williams RH, [Pavlik VN](https://profiles.viictr.org/profile/269512), Cooper P, Migliore PJ. Pitfalls in interpreting prostate specific antigen velocity. J Urol. 1996 May; 155(5):1655-7. PMID: [8627846](//www.ncbi.nlm.nih.gov/pubmed/8627846).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8627846/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  67. Timme TL, [Yang G](https://profiles.viictr.org/profile/12582752), Rogers E, **Kadmon D** , Morganstern JP, Park SH, [Thompson TC](https://profiles.viictr.org/profile/12582753). Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutions. Lab Invest. 1996 Apr; 74(4):747-60. PMID: [8606485](//www.ncbi.nlm.nih.gov/pubmed/8606485).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8606485/citedby/) Fields:

Cli Clinical Laboratory TechniquesPat Pathology

Translation:HumansAnimalsCells

  68. [Thompson TC](https://profiles.viictr.org/profile/12582753), Park SH, Timme TL, Ren C, Eastham JA, [Donehower LA](https://profiles.viictr.org/profile/268019), Bradley A, **Kadmon D** , [Yang G](https://profiles.viictr.org/profile/12582752). Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. Oncogene. 1995 Mar 02; 10(5):869-79. PMID: [7534899](//www.ncbi.nlm.nih.gov/pubmed/7534899).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7534899/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:AnimalsCells

  69. Andriole G, Lieber M, Smith J, Soloway M, Schroeder F, **Kadmon D** , DeKernion J, Rajfer J, Boake R, Crawford D, et al. Treatment with finasteride following radical prostatectomy for prostate cancer. Urology. 1995 Mar; 45(3):491-7. PMID: [7533461](//www.ncbi.nlm.nih.gov/pubmed/7533461).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7533461/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  70. Timme TL, Truong LD, Slawin KM, **Kadmon D** , Park SH, [Thompson TC](https://profiles.viictr.org/profile/12582753). Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth. Microsc Res Tech. 1995 Mar 01; 30(4):333-41. PMID: [7541677](//www.ncbi.nlm.nih.gov/pubmed/7541677).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7541677/citedby/) Fields:

Dia Diagnostic Imaging

Translation:Animals

  71. Timme TL, [Yang G](https://profiles.viictr.org/profile/12582752), Truong LD, **Kadmon D** , Park SH, [Thompson TC](https://profiles.viictr.org/profile/12582753). Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities. World J Urol. 1995; 13(6):324-8. PMID: [9116750](//www.ncbi.nlm.nih.gov/pubmed/9116750).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9116750/citedby/) Fields:

Uro Urology

Translation:HumansAnimals

  72. Feeney D, Quesada ET, Sirbasku DM, **Kadmon D**. Transitional cell carcinoma in a tuberculous kidney: case report and review of the literature. J Urol. 1994 Apr; 151(4):989-91. PMID: [8126846](//www.ncbi.nlm.nih.gov/pubmed/8126846).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8126846/citedby/) Fields:

Uro Urology

Translation:Humans

  73. Timme TL, Truong LD, Merz VW, Krebs T, **Kadmon D** , Flanders KC, Park SH, [Thompson TC](https://profiles.viictr.org/profile/12582753). Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology. 1994 Mar; 134(3):1039-45. PMID: [8119140](//www.ncbi.nlm.nih.gov/pubmed/8119140).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8119140/citedby/) Fields:

End Endocrinology

Translation:Animals

  74. Slawin K, **Kadmon D** , Park SH, Scardino PT, Anzano M, Sporn MB, [Thompson TC](https://profiles.viictr.org/profile/12582753). Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res. 1993 Oct 01; 53(19):4461-5. PMID: [8402613](//www.ncbi.nlm.nih.gov/pubmed/8402613).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8402613/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  75. [Thompson TC](https://profiles.viictr.org/profile/12582753), Truong LD, Timme TL, **Kadmon D** , McCune BK, Flanders KC, Scardino PT, Park SH. Transgenic models for the study of prostate cancer. Cancer. 1993 Feb 01; 71(3 Suppl):1165-71. PMID: [8428340](//www.ncbi.nlm.nih.gov/pubmed/8428340).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8428340/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  76. [Thompson TC](https://profiles.viictr.org/profile/12582753), Timme TL, **Kadmon D** , Park SH, Egawa S, Yoshida K. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Mol Carcinog. 1993; 7(3):165-79. PMID: [8489712](//www.ncbi.nlm.nih.gov/pubmed/8489712).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8489712/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:AnimalsCells

  77. Truong LD, **Kadmon D** , McCune BK, Flanders KC, Scardino PT, [Thompson TC](https://profiles.viictr.org/profile/12582753). Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study. Hum Pathol. 1993 Jan; 24(1):4-9. PMID: [7678092](//www.ncbi.nlm.nih.gov/pubmed/7678092).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7678092/citedby/) Fields:

Pat Pathology

Translation:HumansCells

  78. [Thompson TC](https://profiles.viictr.org/profile/12582753), Egawa S, **Kadmon D** , Miller GJ, Timme TL, Scardino PT, Park SH. Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas. J Steroid Biochem Mol Biol. 1992 Sep; 43(1-3):79-85. PMID: [1525069](//www.ncbi.nlm.nih.gov/pubmed/1525069).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1525069/citedby/) Fields:

Bio BiochemistryMol Molecular Biology

Translation:AnimalsCells

  79. **Kadmon D**. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO). J Cell Biochem Suppl. 1992; 16H:122-7. PMID: [1289667](//www.ncbi.nlm.nih.gov/pubmed/1289667).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1289667/citedby/) Fields:

Bio BiochemistryCel Cell Biology

Translation:HumansAnimals

  80. Egawa S, **Kadmon D** , Miller GJ, Scardino PT, [Thompson TC](https://profiles.viictr.org/profile/12582753). Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma. Mol Carcinog. 1992; 5(1):52-61. PMID: [1543541](//www.ncbi.nlm.nih.gov/pubmed/1543541).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1543541/citedby/) Fields:

Mol Molecular BiologyNeo Neoplasms

Translation:AnimalsCells

  81. [Thompson TC](https://profiles.viictr.org/profile/12582753), Truong LD, Timme TL, **Kadmon D** , McCune BK, Flanders KC, Scardino PT, Park SH. Transforming growth factor beta 1 as a biomarker for prostate cancer. J Cell Biochem Suppl. 1992; 16H:54-61. PMID: [1289674](//www.ncbi.nlm.nih.gov/pubmed/1289674).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1289674/citedby/) Fields:

Bio BiochemistryCel Cell Biology

Translation:HumansAnimals

  82. Moss JT, **Kadmon D**. BCG and the treatment of superficial bladder cancer. DICP. 1991 Dec; 25(12):1355-67. PMID: [1815434](//www.ncbi.nlm.nih.gov/pubmed/1815434).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1815434/citedby/)
Translation:Humans

  83. **Kadmon D** , [Thompson TC](https://profiles.viictr.org/profile/12582753), [Lynch GR](https://profiles.viictr.org/profile/269644), Scardino PT. Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J Urol. 1991 Aug; 146(2):358-61. PMID: [1856931](//www.ncbi.nlm.nih.gov/pubmed/1856931).

Citations:
[16](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1856931/citedby/) Fields:

Uro Urology

Translation:Humans

  84. Merz VW, Miller GJ, Krebs T, Timme TL, **Kadmon D** , Park SH, Egawa S, Scardino PT, [Thompson TC](https://profiles.viictr.org/profile/12582753). Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression. Mol Endocrinol. 1991 Apr; 5(4):503-13. PMID: [1922083](//www.ncbi.nlm.nih.gov/pubmed/1922083).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1922083/citedby/) Fields:

End EndocrinologyMol Molecular Biology

Translation:Animals

  85. [Thompson TC](https://profiles.viictr.org/profile/12582753), **Kadmon D** , Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH. Experimental oncogene induced prostate cancer. Cancer Surv. 1991; 11:55-71. PMID: [1726789](//www.ncbi.nlm.nih.gov/pubmed/1726789).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1726789/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  86. Hwang DR, Mathias CJ, Welch MJ, McGuire AH, **Kadmon D**. Imaging prostate derived tumors with PET and N-(3-[18F]fluoropropyl)putrescine. Int J Rad Appl Instrum B. 1990; 17(6):525-32. PMID: [2254090](//www.ncbi.nlm.nih.gov/pubmed/2254090).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2254090/citedby/) Fields:

Bio BiologyNuc Nuclear Medicine

Translation:HumansAnimals

  87. Hwang DR, Lang LX, Mathias CJ, **Kadmon D** , Welch MJ. N-3-[18F]fluoropropylputrescine as potential PET imaging agent for prostate and prostate derived tumors. J Nucl Med. 1989 Jul; 30(7):1205-10. PMID: [2500502](//www.ncbi.nlm.nih.gov/pubmed/2500502).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2500502/citedby/) Fields:

Nuc Nuclear Medicine

Translation:HumansAnimalsCells

  88. Shabsigh R, [Lerner S](https://profiles.viictr.org/profile/267959), Fishman IJ, **Kadmon D**. The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. J Urol. 1989 May; 141(5):1206-9. PMID: [2651723](//www.ncbi.nlm.nih.gov/pubmed/2651723).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2651723/citedby/) Fields:

Uro Urology

Translation:Humans

  89. Heston WD, **Kadmon D**. alpha-Difluoromethylornithine enhancement of 14C-putrescine uptake by an androgen-dependent prostatic tumor. J Urol. 1986 Oct; 136(4):944-8. PMID: [3093695](//www.ncbi.nlm.nih.gov/pubmed/3093695).

Citations:  Fields:

Uro Urology

Translation:Animals

  90. **Kadmon D** , Ling D, Lee JK. Percutaneous drainage of prostatic abscesses. J Urol. 1986 Jun; 135(6):1259-60. PMID: [3520019](//www.ncbi.nlm.nih.gov/pubmed/3520019).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3520019/citedby/) Fields:

Uro Urology

Translation:Humans

  91. Kavoussi LR, Levine SR, **Kadmon D** , Fair WR. Regression of metastatic renal cell carcinoma: a case report and literature review. J Urol. 1986 May; 135(5):1005-7. PMID: [3959224](//www.ncbi.nlm.nih.gov/pubmed/3959224).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3959224/citedby/) Fields:

Uro Urology

Translation:Humans

  92. Hwang DR, Jerabek PA, **Kadmon D** , Kilbourn MR, Patrick TB, Welch MJ. 2-[18F]fluoroputrescine: preparation, biodistribution, and mechanism of defluorination. Int J Rad Appl Instrum A. 1986; 37(7):607-12. PMID: [3021663](//www.ncbi.nlm.nih.gov/pubmed/3021663).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3021663/citedby/) Fields:

Nuc Nuclear MedicineRad Radiology

Translation:Animals

  93. Jerabek PA, Dence CS, Kilbourn MR, Welch MJ, **Kadmon D**. Synthesis and uptake of no-carrier-added 1-[11C]putrescine into rat prostate. Int J Nucl Med Biol. 1985; 12(5):349-52. PMID: [3833820](//www.ncbi.nlm.nih.gov/pubmed/3833820).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3833820/citedby/) Fields:

Bio BiologyNuc Nuclear Medicine

Translation:Animals

  94. **Kadmon D** , Mahle C, Heston WD, Hahn DA. Effect of estrogen and androgen administration on alpha-difluoromethylornithine-enhanced putrescine uptake by the rat prostate. Prostate. 1985; 6(4):343-9. PMID: [3937149](//www.ncbi.nlm.nih.gov/pubmed/3937149).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/3937149/citedby/) Fields:

Uro Urology

Translation:Animals

  95. Ratliff TL, **Kadmon D** , Shapiro A, Jacobs AJ, Heston WD. Inhibition of mouse bladder tumor proliferation by murine interferon-gamma and its synergism with interferon-beta. Cancer Res. 1984 Oct; 44(10):4377-81. PMID: [6432311](//www.ncbi.nlm.nih.gov/pubmed/6432311).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6432311/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  96. Heston WD, **Kadmon D** , Covey DF, Fair WR. Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor. Cancer Res. 1984 Mar; 44(3):1034-40. PMID: [6420052](//www.ncbi.nlm.nih.gov/pubmed/6420052).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6420052/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  97. Shapiro A, **Kadmon D** , Catalona WJ, Ratliff TL. Immunotherapy of superficial bladder cancer. J Urol. 1982 Nov; 128(5):891-4. PMID: [6184490](//www.ncbi.nlm.nih.gov/pubmed/6184490).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6184490/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  98. **Kadmon D** , Heston WD, Lazan DW, Fair WR. Difluoromethylornithine enhancement of putrescine uptake into the prostate: concise communication. J Nucl Med. 1982 Nov; 23(11):998-1002. PMID: [6813433](//www.ncbi.nlm.nih.gov/pubmed/6813433).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6813433/citedby/) Fields:

Nuc Nuclear Medicine

Translation:Animals

  99. Fair WR, Heston WD, **Kadmon D** , Crane DB, Catalona WJ, Ladenson JH, McDonald JM, Noll BW, Harvey G. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study. J Urol. 1982 Oct; 128(4):735-8. PMID: [6183457](//www.ncbi.nlm.nih.gov/pubmed/6183457).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6183457/citedby/) Fields:

Uro Urology

Translation:Humans

  100. **Kadmon D** , Heston WD, Fair WR. Treatment of a metastatic prostate derived tumor with surgery and chemotherapy. J Urol. 1982 Jun; 127(6):1238-42. PMID: [7087045](//www.ncbi.nlm.nih.gov/pubmed/7087045).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7087045/citedby/) Fields:

Uro Urology

Translation:Animals

  101. Heston WD, **Kadmon D** , Fair WR. Growth inhibition of a prostate tumor by alpha-difluoromethylornithine and by cyclophosphamide. Cancer Lett. 1982 May-Jun; 16(1):71-79. PMID: [6811130](//www.ncbi.nlm.nih.gov/pubmed/6811130).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6811130/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  102. Lazan DW, Heston WD, **Kadmon D** , Fair WR. Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Res. 1982 Apr; 42(4):1390-4. PMID: [7060012](//www.ncbi.nlm.nih.gov/pubmed/7060012).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7060012/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  103. Heston WD, **Kadmon D** , Lazan DW, Fair WR. Copenhagen rat prostatic tumor ornithine decarboxylase activity (ODC) and the effect of the ODC inhibitor alpha-difluoromethylornithine. Prostate. 1982; 3(4):383-9. PMID: [6812032](//www.ncbi.nlm.nih.gov/pubmed/6812032).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6812032/citedby/) Fields:

Uro Urology

Translation:AnimalsCells

  104. Heston WD, **Kadmon D** , Fair WR. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor. Cancer Lett. 1981 Jul; 13(2):139-45. PMID: [7306951](//www.ncbi.nlm.nih.gov/pubmed/7306951).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7306951/citedby/) Fields:

Neo Neoplasms

Translation:Animals

  105. **Kadmon D** , Heston WD, Fair WR. Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumor. Prostate. 1981; 2(3):299-307. PMID: [7301657](//www.ncbi.nlm.nih.gov/pubmed/7301657).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7301657/citedby/) Fields:

Uro Urology

Translation:Animals

  106. Catalona WJ, **Kadmon D** , Crane DB. Effect of mini-dose heparin on lymphocele formation following extraperitoneal pelvic lymphadenectomy. J Urol. 1980 Jun; 123(6):890-2. PMID: [7382008](//www.ncbi.nlm.nih.gov/pubmed/7382008).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7382008/citedby/) Fields:

Uro Urology

Translation:Humans

  107. Catalona WJ, **Kadmon D** , Martin SA. Surgical considerations in treatment of intraductal carcinoma of the prostate. J Urol. 1978 Aug; 120(2):259-61. PMID: [209223](//www.ncbi.nlm.nih.gov/pubmed/209223).

Citations: [4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/209223/citedby/)
Fields:

Uro Urology

Translation:Humans

  108. **Kadmon D** , Rozin R, Merhav A, Pappu J. [Multiple giant hepatic hemangiomas]. Harefuah. 1976 May 16; 90(10):470-3. PMID: [964729](//www.ncbi.nlm.nih.gov/pubmed/964729).

Citations:  Fields:

Med Medicine (General)

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 73 publications over 20 distinct years, with a maximum of
9 publications in 2000 and
2001](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|9&cht=bvs&chd=t:22,44,33,0,22,11,100,100,67,22,78,44,56,56,56,11,11,11,0,22,0,0,0,22,0,0,0,0,0,0,22&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 2  
1995| 4  
1996| 3  
1998| 2  
1999| 1  
2000| 9  
2001| 9  
2002| 6  
2003| 2  
2004| 7  
2005| 4  
2006| 5  
2007| 5  
2008| 5  
2009| 1  
2010| 1  
2011| 1  
2013| 2  
2017| 2  
2024| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

KADMON's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (402)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Prostatic Neoplasms](https://profiles.viictr.org/profile/245090)
  * [Genetic Therapy](https://profiles.viictr.org/profile/245396)
  * [Prostatectomy](https://profiles.viictr.org/profile/257039)
  * [Prostate-Specific Antigen](https://profiles.viictr.org/profile/257452)
  * [Prostate](https://profiles.viictr.org/profile/240275)

[Explore](https://profiles.viictr.org/profile/268024/198)

_

Co-Authors (30)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [THOMPSON, TIMOTHY](https://profiles.viictr.org/profile/12582753)
  * [WHEELER, THOMAS](https://profiles.viictr.org/profile/266558)
  * [MILES, BRIAN](https://profiles.viictr.org/profile/268161)
  * [SLAWIN, JEREMY](https://profiles.viictr.org/profile/38937051)
  * [ITTMANN, MICHAEL](https://profiles.viictr.org/profile/269566)

[Explore](https://profiles.viictr.org/profile/268024/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [THOMPSON, TIMOTHY](https://profiles.viictr.org/profile/12582753)
  * [LOGOTHETIS, CHRISTOPHER J](https://profiles.viictr.org/profile/12583246)
  * [KUBAN, DEBORAH A](https://profiles.viictr.org/profile/12583748)
  * [CHAPIN, BRIAN FRANCIS](https://profiles.viictr.org/profile/12582802)
  * [ITTMANN, MICHAEL](https://profiles.viictr.org/profile/269566)

[Explore](https://profiles.viictr.org/profile/268024/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [BABAIAN, KARA](https://profiles.viictr.org/profile/41415757)
  * [CHERIYAN, SALIM](https://profiles.viictr.org/profile/31893995)
  * [KHAVARI, ROSE](https://profiles.viictr.org/profile/9909039)
  * [LAWRENCE, AMY](https://profiles.viictr.org/profile/28999007)
  * [ROBERTS, WILMER](https://profiles.viictr.org/profile/32757287)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [JORGEZ, CAROLINA](https://profiles.viictr.org/profile/266145)
  * [KHERA, MOHIT](https://profiles.viictr.org/profile/266483)
  * [LERNER, SETH](https://profiles.viictr.org/profile/267959)
  * [LINK, RICHARD](https://profiles.viictr.org/profile/266761)
  * [SMITH, CHRISTOPHER](https://profiles.viictr.org/profile/266749)

_

